Product Information
BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.2138 per EA under NDC 70954041210. Its NADAC has been published 163 times since Jul 13, 2022.
The High Outlier badge above means this manufacturer's average price in the Bisoprolol Fumarate and Hydrochlorothiazide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB
Bisoprolol Fumarate and HydrochlorothiazideStrength
2.5; 6.25 mg/1; mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
70954041210
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
8/20/2025
Active Ingredients
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215562On Market Since
11/4/2021
Pharmacological Classes
Price Statistics
The NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB has been published 163 times since Jul 13, 2022, and over the history we have for it it has declined 40.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2138 per EA |
|---|---|
| All-time high | $0.3594 (Jul 13, 2022) |
| All-time low | $0.1729 (Nov 20, 2024) |
| 52-week high | $0.2138 |
| 52-week low | $0.2056 |
| Median price | $0.2532 |
| Average price | $0.2540 |
| Largest weekly change | +63.0% (Nov 22, 2023) |
| Weeks tracked | 163 |
| Tracking since | Jul 13, 2022 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB, manufactured by ANI Pharmaceuticals, Inc., is $0.2138 per EA (NDC 70954041210), effective Aug 20, 2025.
How has the price of BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB changed over time?
Over the history we have for it, the NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB has declined 40.5%. It has been tracked across 163 weekly CMS publications since Jul 13, 2022.
What are the highest and lowest recorded NADAC prices for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?
Since Jul 13, 2022, the NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB has ranged from a low of $0.1729 (Nov 20, 2024) to a high of $0.3594 (Jul 13, 2022), with a median of $0.2532 per EA.
Are there cheaper alternatives to BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB, is $0.1862 per EA — about 13% below BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB.
Who manufactures BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?
BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB (NDC 70954041210) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification